Benzinga | Jun 2, 2021 07:04AM EDT

Citigroup Maintains Buy on Abbott Laboratories, Lowers Price Target to $125

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $138 to $125.